MedPath

China Collaborative Study on Epidemiology of Acute Kidney Injury

Recruiting
Conditions
Acute Kidney Injury
Interventions
Other: no intervention
Registration Number
NCT03054142
Lead Sponsor
XinLing Liang
Brief Summary

Acute kidney injury (AKI) is a common clinical syndrome, especially patients in the hospital. AKI has become a huge medical burden in China. Little information is available about this disease burden in our country. The investigators aimed to evaluate the burden of AKI and to analyze the related risk factors.

Detailed Description

The investigators launch a nationwide of all patients, who were admitted to hospital from 2011-2016. Patients were diagnosed on the basis of changes in serum creatinine by the laboratory information system. The investigators assessed rates of AKI according to the criteria of 2012 Kidney Disease Improving Global Outcomes (KDIGO).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000000
Inclusion Criteria
  • The patients diagnosed on the basis of changes in serum creatinine according to the criteria of 2012 Kidney Disease Improving Global Outcomes(KDIGO)
Exclusion Criteria
  • Serum creatinine record less than two times during hospitalization
  • Patients being diagnosed with End-stage kidney disease (chronic kidney disease stage 5)
  • Nephrectomy
  • Kidney transplantation
  • Peak serum creatinine of less than 53µ mol/L
  • Serum creatinine decrease after amputation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
non-AKIno intervention-
AKIno intervention-
Primary Outcome Measures
NameTimeMethod
Incidence of AKIJan. 2011 to Oct. 2016
Secondary Outcome Measures
NameTimeMethod
Longer ICU stayJan. 2011 to Oct. 2016
In-hospital mortalityJan. 2011 to Oct. 2016
Recognition rate of AKIJan. 2011 to Oct. 2016

Using machine learning and deep learning methods to establish AKI prediction model and risk models

Proportion of nephrology referralJan. 2011 to Oct. 2016
Higher medical costJan. 2011 to Oct. 2016

Trial Locations

Locations (1)

Nephrology Dept,Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath